Clinical Trial Update: Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - Phase 2 Clinical Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for photodynamic therapy using Metil 5-aminolevulinate targeting actinic cheilitis and leukoplakia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Cheilitis
• Erythroplakia
• Leukoplakia

Drugs mentioned

• Metil 5-aminolevulinate (5-aminolevulinic acid methyl ester)

Snippet

Sponsor: Instituto Nacional de Cancer, Brazil | Conditions: Actinic Cheilitis, Leukoplakia | Phase 2 | Status: UNKNOWN